Skip to content
Disclosery

Healthcare Value Capital, LLC

Follow

13F filer, CIK 1458461, Woodcliff Lake, NJ

Healthcare Value Capital, LLC reported $30,344,000 across 18 holdings for the quarter ended 2020-09-30, in a 13F-HR filed 2020-11-16. Its ten largest share positions make up 92.14% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000919574-20-007048

Period
2020-09-30
Reported value
$30.3M
Holdings
18
Top 10 weight
92.14%
New
5
Sold out
6

Largest buys vs the previous quarter

SecurityShares changeApprox. value
VYNE THERAPEUTICS INCnew+1,800,000$2.99M
ABBVadded+10,000$876K
JAZZadded+6,000$856K
ADAMAS PHARMACEUTICALS INCnew+100,000$412K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
MENLO THERAPEUTICS INCexited-1,700,000-$2.94M
WALGREENS BOOTS ALLIANCE INCexited-50,000-$2.12M
CVSexited-25,000-$1.62M
CORexited-15,000-$1.51M
CAHreduced-25,000-$1.17M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2020

Share positions as resolved from 13F-HR 0000919574-20-007048, largest first. % of portfolio is the value over $27,293,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
GLAXOSMITHKLINE PLC-ADRGLAXOSMITHKLINE PLC-ADRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: 100,000 shares; 2020Q1: 100,000 shares; 2020Q2: 100,000 shares; 2020Q3: 100,000 shares 100,000$3.76M13.79%0
JAZZJAZZ PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: not reported; 2020Q1: 30,000 shares; 2020Q2: 19,000 shares; 2020Q3: 25,000 shares 25,000$3.56M13.06%+6,000Timeline
GILDGILEAD SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: 70,000 shares; 2020Q1: 50,000 shares; 2020Q2: 50,000 shares; 2020Q3: 50,000 shares 50,000$3.16M11.58%0Timeline
ABBVABBVIE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: 50,000 shares; 2020Q1: 50,000 shares; 2020Q2: 25,000 shares; 2020Q3: 35,000 shares 35,000$3.07M11.23%+10,000Timeline
VYNE THERAPEUTICS INCVYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: not reported; 2020Q1: not reported; 2020Q2: not reported; 2020Q3: 1,800,000 shares 1,800,000$2.99M10.95%new
INVESCO QQQ TRUST SERIES 1INVESCO QQQ TRUST SERIES 1Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: not reported; 2020Q1: 150,000 shares; 2020Q2: 250,000 shares; 2020Q3: 250,000 shares 250,000$2.17M7.97%0
TYME TECHNOLOGIES INC COMTYME TECHNOLOGIES INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: 2,175,000 shares; 2020Q1: 2,175,000 shares; 2020Q2: 2,175,000 shares; 2020Q3: 2,175,000 shares 2,175,000$2.13M7.81%0
MCKMCKESSON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: 10,000 shares; 2020Q1: 25,000 shares; 2020Q2: 10,000 shares; 2020Q3: 10,000 shares 10,000$1.49M5.46%0Timeline
CLOVIS ONCOLOGY INCCLOVIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: 150,000 shares; 2020Q1: 250,000 shares; 2020Q2: 250,000 shares; 2020Q3: 250,000 shares 250,000$1.46M5.34%0
ANTARES PHARMA INCANTARES PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: 300,000 shares; 2020Q1: 500,000 shares; 2020Q2: 500,000 shares; 2020Q3: 500,000 shares 500,000$1.35M4.95%0
CAHCARDINAL HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: 35,000 shares; 2020Q1: 75,000 shares; 2020Q2: 50,000 shares; 2020Q3: 25,000 shares 25,000$1.17M4.3%-25,000Timeline
GREENLANE HLDGS INCGREENLANE HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: 175,000 shares; 2020Q1: 225,000 shares; 2020Q2: 250,000 shares; 2020Q3: 250,000 shares 250,000$560K2.05%0
ADAMAS PHARMACEUTICALS INCADAMAS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q4: restricted; 2019Q1: restricted; 2019Q2: restricted; 2019Q3: restricted; 2019Q4: not reported; 2020Q1: not reported; 2020Q2: not reported; 2020Q3: 100,000 shares 100,000$412K1.51%new

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
INVESCO QQQ TRUST SERIES 1INVESCO QQQ TRUST SERIES 1 ULTRAPRO SHORT Scall100,000$870K-100,000
MRNAMODERNA INC COMput10,000$708Knew
NVAXNOVAVAX INC COM NEWput5,000$542Knew
Proshares VIX Short-TermProshares VIX Short-Term Equitycall25,000$510Knew
AMARIN CORP PLCAMARIN CORP PLC SPONS ADR NEWcall100,000$421K0

Sold out in Q3 2020

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
MENLO THERAPEUTICS INCMENLO THERAPEUTICS INC1,700,000$2.94Mshares
WALGREENS BOOTS ALLIANCE INCWALGREENS BOOTS ALLIANCE INC50,000$2.12Mshares
CVSCVS HEALTH CORP25,000$1.62Mshares
CORCENCORA INC15,000$1.51Mshares
VKTXVIKING THERAPEUTICS INC100,000$721Kcall
CLOVIS ONCOLOGY INCCLOVIS ONCOLOGY INC100,000$675Kcall

How Q3 2020 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000919574-20-007048 base2020-11-16acceptance time not in the bulk data set